Korro Bio
RNA editing
0 open roles RNA editing Cambridge, Massachusetts, United States 76 employees Est. 2018
Venrock Healthcare Capital Partners
ADAR1 Capital Management
Affinity Asset Advisors
Balyasny Asset Management
Driehaus Capital Management
Kalehua Capital
About Korro Bio
Korro Bio is a clinical-stage biotechnology company focused on programmable RNA editing to develop genetic medicines for rare and prevalent diseases.
Korro Bio is listed on Rocketlist with 0 active roles. The company is categorized as RNA editing in BioTech. Korro Bio is at Public stage, with a B2B and B2C business model, headquartered in Cambridge, Massachusetts, United States. Korro Bio was founded in 2018 and has 76 employees. Active roles are refreshed daily from public hiring sources.